Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Depreciation & Amortization (CF) (2016 - 2025)

Lipocine's Depreciation & Amortization (CF) history spans 12 years, with the latest figure at $14123.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 65.94% year-over-year to $14123.0; the TTM value through Sep 2025 reached $61372.0, up 82.99%, while the annual FY2024 figure was $41106.0, 43.42% up from the prior year.
  • Depreciation & Amortization (CF) reached $14123.0 in Q3 2025 per LPCN's latest filing, down from $16108.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $16108.0 in Q2 2025 to a low of $1719.0 in Q1 2022.
  • Average Depreciation & Amortization (CF) over 4 years is $8334.7, with a median of $8091.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): surged 213.85% in 2023, then rose 5.2% in 2024.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $2578.0 in 2022, then surged by 210.43% to $8003.0 in 2023, then soared by 94.56% to $15571.0 in 2024, then decreased by 9.3% to $14123.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Depreciation & Amortization (CF) are $14123.0 (Q3 2025), $16108.0 (Q2 2025), and $15570.0 (Q1 2025).